1,389 research outputs found
DSDV, DYMO, OLSR: Link Duration and Path Stability
In this paper, we evaluate and compare the impact of link duration and path
stability of routing protocols; Destination Sequence Distance vector (DSDV),
Dynamic MANET On- Demand (DYMO) and Optimized Link State Routing (OLSR) at
different number of connections and node density. In order to improve the
efficiency of selected protocols; we enhance DYMO and OLSR. Simulation and
comparison of both default and enhanced routing protocols is carried out under
the performance parameters; Packet Delivery Ratio (PDR), Average End-to End
Delay (AE2ED) and Normalized Routing Overhead (NRO). From the results, we
observe that DYMO performs better than DSDV, MOD-OLSR and OLSR in terms of PDR,
AE2ED, link duration and path stability at the cost of high value of NRO
Modeling and Evaluating Enhancements in Expanding Ring Search Algorithm for Wireless Reactive Protocols
In case of high dynamic topology, reactive routing protocols provide quick
convergence by faster route discoveries and route maintenance. Frequent
roadcasts reduce routing efficiency in terms of broadcast cost; Bk, and
expected time cost; E[t]. These costs are optimized using different mechanisms.
So, we select three reactive routing protocols; Ad-hoc On-demand Distance
Vector (AODV), Dynamic Source Routing (DSR), and DYnamic Manet On-demad (DYMO).
We model expanding Ring Search (ERS); an optimization mechanism in the selected
protocols to reduce Bk and E[t]. A novel contribution of this work is
enhancement of default ERS in the protocols to optimize Bk and E[t]. Using
NS-2, we evaluate and compare default-ERS used by these protocols; AODV-ERS1,
DSR-ERS1 and DYMO-ERS1 with enhanced-ERS; AODVERS2, DSR-ERS2 and DYMO-ERS2.
From modeling and analytical comparison, we deduce that by adjusting
Time-To-Live (T TL) value of a network, efficient optimizations of Bk and E[t]
can be achieved.Comment: 25th IEEE CCECE, 2012, Montreal Canad
Analysis and Modeling Experiment Performance Parameters of Routing Protocols in MANETs and VANETs
In this paper, a framework for experimental parameters in which Packet
Delivery Ratio (PDR), effect of link duration over End-to-End Delay (E2ED) and
Normalized Routing Overhead (NRO) in terms of control packets is analyzed and
modeled for Mobile Ad-Hoc NETworks (MANETs) and Vehicular Ad-Hoc NETworks
(VANETs) with the assumption that nodes (vehicles) are sparsely moving in two
different road. Moreover, this paper contributes the performance comparison of
one Proactive Routing Protocol; Destination Sequenced Distance vector (DSDV)
and two reactive protocols; DYnamic Source Routing (DSR) and DYnamic MANET
On-Demand (DYMO). A novel contribution of this work is enhancements in default
versions of selected routing protocols. Three performance parameters; PDR, E2ED
and NRO with varying scalabilities are measured to analyze the performance of
selected routing protocols with their original and enhanced versions. From
extensive simulations, it is observed that DSR outperforms among all three
protocols at the cost of delay. NS-2 simulator is used for simulation with
TwoRayGround propagation model to evaluate analytical results
Preliminary study of haplotypes linked to the rare cystic fibrosis E1104X mutation
The analysis of some extra- and intragenic markers within or closely linked to the cystic fibrosis transmembrane regulator (CFTR) gene is useful as a molecular method in clinical linkage analysis. Indeed, knowing that the molecular basis of cystic fibrosis (CF) is highly heterogeneous in our population, the study of haplotype association with normal and CF chromosomes could be very helpful in cases where one or both mutations remain unidentified. In this study, we analysed with PCR-RFLP and capillary electrophoresis some extra (pJ3.11, KM19 and XV2C) and intragenic (IVS8CA, IVS17bTA and IVS17bCA) polymorphic markers in 50 normal and 10 Tunisian patients carrying the rare E1104X mutation in order to determine the haplotype associated with this mutation. For the extragenic markers, 8 haplotypes were identified. The most frequent of them are the 221 and 112 accounting for 80% of total haplotypes. For the intragenic markers, five haplotypes were present on the E1104X chromosomes. One of them 16-31-13 accounted for 50%. To our knowledge, this is the first work to be interested to the haplotypes linked to the E1104X mutation. This preliminary study of haplotypes could be a helpful method to determine the molecular lesions responsible of this pathology
Influence of frequency and duration of strength training for effective management of neck and shoulder pain:a randomised controlled trial
BACKGROUND: Specific strength training can reduce neck and shoulder pain in office workers, but the optimal combination of exercise frequency and duration remains unknown. This study investigates how one weekly hour of strength training for the neck and shoulder muscles is most effectively distributed. METHODS: A total of 447 office workers with and without neck and/or shoulder pain were randomly allocated at the cluster-level to one of four groups; 1×60 (1WS), 3×20 (3WS) or 9×7 (9WS) min a week of supervised high-intensity strength training for 20 weeks, or to a reference group without training (REF). Primary outcome was self-reported neck and shoulder pain (scale 0–9) and secondary outcome work disability (Disability in Arms, Shoulders and Hands (DASH)). RESULTS: The intention-to-treat analysis showed reduced neck and right shoulder pain in the training groups after 20 weeks compared with REF. Among those with pain ≥3 at baseline (n=256), all three training groups achieved significant reduction in neck pain compared with REF (p<0.01). From a baseline pain rating of 3.2 (SD 2.3) in the neck among neck cases, 1WS experienced a reduction of 1.14 (95% CI 0.17 to 2.10), 3WS 1.88 (0.90 to 2.87) and 9WS 1.35 (0.24 to 2.46) which is considered clinically significant. DASH was reduced in 1WS and 3WS only. CONCLUSION: One hour of specific strength training effectively reduced neck and shoulder pain in office workers. Although the three contrasting training groups showed no statistical differences in neck pain reduction, only 1WS and 3WS reduced DASH. This study suggests some flexibility regarding time-wise distribution when implementing specific strength training at the workplace
Effect of compost addition on arsenic uptake, morphological and physiological attributes of maize plants grown in contrasting soils
Contamination of soils with arsenic (As) represents a global environmental and health issue considering the entrance of toxic As in the human food chain. Although partially understood, addition of compost for the remediation of As-contaminated soils may result in distinct effects on plant growth and physiological attributes depending on compost-mediated potential mobility/sequestration of As in soils. This study explores the role of compost addition (C; 0, 1 and 2.5%) on morphological and gas exchange attributes and photosynthetic pigments (chlorophyll contents) of maize plants under As stress (0, 40, 80, 120 mg kg− 1), as well as soil As immobilization/mobilization in a pot experiment, using two contrasting soils. Results revealed that, in Narwala (sandy loam) soil, the addition of compost decreased shoot As concentration of maize plants (p < 0.05; 4.01–13.7 mg kg− 1 dry weight (DW)), notably at C2.5 treatment, with significant improvement in shoot dry biomass, gas exchange attributes and chlorophyll (a and b) contents, i.e., 1.33–1.82, 1.20–2.65 and 1.34–1.66 times higher, respectively, over C0 at all As levels. Contrastingly, in Shahkot (clay loam) soil, C2.5 treatment increased shoot As concentration (p < 0.05; 7.02–17.3 mg kg− 1 DW), and as such reduced the shoot dry biomass, gas exchange attributes and chlorophyll contents, compared to the control – rather C1 treatment was more effective and exhibited positive effect than C2.5. Considerably, at C2.5 treatment, phosphate extractable (bioavailable) soil As concentration was also found to be greater in the (post-experiment) Shahkot soil than that of Narwala soil (0.40–3.82 vs. 0.19–1.51 mg kg− 1, respectively). This study advanced our understanding to resolve the complex compost-As interactions in As-contaminated soils, which are imperative to understand for developing the effective and soil-specific remediation strategies
RETURNEES: WHO ARE THEY, WHY ARE THEY (NOT) COMING BACK AND HOW SHOULD WE DEAL WITH THEM? Assessing Policies on Returning Foreign Terrorist Fighters in Belgium, Germany and the Netherlands. Egmont Paper 101, February 2018
Some 5000 men, women and children have travelled from Europe to Syria and Iraq since 2012. An estimated 1500 of these foreign terrorist fighters (FTF) have returned so far. Belgium, Germany and the Netherlands represent a third of European FTF and returnees. This report looks into the evolution of policies on returning foreign fighters in these three countries, comparing responses with regard to fighters that are still in the conflict zone, policies to deal with returnees in prison and attitudes towards the children of foreign fighters. It is the very first systematic and in-depth study into national approaches and policies vis-à-vis returnees. Its added value lies in the wealth of data, including data that has not been published before, and in the comparative angle
A preliminary investigation to group disparate batches of licit and illicit diazepam tablets using differential scanning calorimetry
Increasing numbers of illicit and unlicensed medicines are in general circulation and regularly seized by the police and other regulatory authorities. Forensic identification of seized tablets tends to focus on visual appearance and chromatographic identification of the contained drug. This process is relatively time consuming and places a strain on forensic laboratories. It was therefore of interest to investigate the possible application of differential scanning calorimetry (DSC) as a fast and efficient tool to facilitate the identification of contained drug/s and associated tablet excipients. Sixteen different cases (Cases A to P) of diazepam tablets obtained from Police Scotland were characterised based on visual appearance (colour and manufacturers' logos), physical attributes (size, weight and hardness), drug type, drug quantity (HPLC) and thermal properties (DSC). Raw DSC data was further processed using principal component analysis (PCA) as an objective assessment of the thermograms obtained with a view to statistical grouping of different cases. Cases J/K, M/O and L/P could be paired on visual appearance and Cases B/C/E/G and J/K/L/P on tablet hardness (17–23 and 80–89 N respectively). HPLC indicated that 75% of the cases examined contained diazepam but less than half of these contained the recognised amount (10 mg); Cases B/E/L/P contained phenazepam and J/K contained etizolam. The thermal signatures of individual tablets provided by DSC produced qualitative information about both drugs and excipients, indicating lactose in Cases D/F/H/I/J/K/M/N/O and Emcompress™ in B/E/L/P. In particular, DSC coupled with PCA provided confident groupings of A/C/G, B/E/L/P and H/I/J/K, and specific pairings of B/E, L/P and F/N
X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis
The X-linked inhibitor of apoptosis (XIAP) deficiency is a primary immunodeficiency characterized by Epstein-Barr virus (EBV)-driven hemophagocytic lymphohistiocytosis (HLH), splenomegaly, and colitis. Here, we present, for the first time, granulomatous hepatitis and granulomatous and lymphocytic interstitial lung disease (GLILD) as manifestations of XIAP deficiency. We report successful treatment of GLILD in XIAP deficiency with rituximab and azathioprine and discuss the role of XIAP deficiency in immune dysregulation
Genotype-Phenotype Correlations in Charcot-Marie-Tooth Disease Due to MTMR2 Mutations and Implications in Membrane Trafficking
Charcot-Marie-Tooth type 4 (CMT4) is an autosomal recessive severe form of neuropathy with genetic heterogeneity. CMT4B1 is caused by mutations in the myotubularin-related 2 (MTMR2) gene and as a member of the myotubularin family, the MTMR2 protein is crucial for the modulation of membrane trafficking. To enable future clinical trials, we performed a detailed review of the published cases with MTMR2 mutations and describe four novel cases identified through whole-exome sequencing (WES). The four unrelated families harbor novel homozygous mutations in MTMR2 (NM_016156, Family 1: c.1490dupC; p.Phe498IlefsTer2; Family 2: c.1479+1G>A; Family 3: c.1090C>T; p.Arg364Ter; Family 4: c.883C>T; p.Arg295Ter) and present with CMT4B1-related severe early-onset motor and sensory neuropathy, generalized muscle atrophy, facial and bulbar weakness, and pes cavus deformity. The clinical description of the new mutations reported here overlap with previously reported CMT4B1 phenotypes caused by mutations in the phosphatase domain of MTMR2, suggesting that nonsense MTMR2 mutations, which are predicted to result in loss or disruption of the phosphatase domain, are associated with a severe phenotype and loss of independent ambulation by the early twenties. Whereas the few reported missense mutations and also those truncating mutations occurring at the C-terminus after the phosphatase domain cause a rather mild phenotype and patients were still ambulatory above the age 30 years. Charcot-Marie-Tooth neuropathy and Centronuclear Myopathy causing mutations have been shown to occur in proteins involved in membrane remodeling and trafficking pathway mediated by phosphoinositides. Earlier studies have showing the rescue of MTM1 myopathy by MTMR2 overexpression, emphasize the importance of maintaining the phosphoinositides equilibrium and highlight a potential compensatory mechanism amongst members of this pathway. This proved that the regulation of expression of these proteins involved in the membrane remodeling pathway may compensate each other's loss- or gain-of-function mutations by restoring the phosphoinositides equilibrium. This provides a potential therapeutic strategy for neuromuscular diseases resulting from mutations in the membrane remodeling pathway
- …
